Opportunity Information: Apply for CDC RFA GH11 1119
Apply for CDC RFA GH11 1119
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Implementation of HIV/AIDS Prevention, Care, Support, and Treatment Services and to Provide Technical and Capacity Development Support to Selected Faith Based Institutions in the Republic of Zambia under the President s Emergency Plan for AIDS Relief" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 13, 2011 and posted on Feb 14, 2011.
- Applicants must submit their applications by Apr 20, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $100,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Private institutions of higher education State governments Native American tribal governments (Federally recognized) County governments City or township governments For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Eligible applicants that can apply for this funding opportunity are Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH11-1119) is a PEPFAR-supported cooperative agreement focused on keeping HIV services in Zambia stable and growing while responsibility is deliberately shifted to local leadership. The core idea is continuity: the program is meant to sustain HIV/AIDS prevention, clinical care, support services, and antiretroviral treatment that were previously established under the PEPFAR-funded HHS/HRSA HIV clinical services and ART program, especially at a defined set of HHS/HRSA-supported sites (referenced as an appendix in the full announcement). Rather than starting something new from scratch, the award supports an orderly handoff from an existing implementing partner to selected local organization(s) that will take over delivery and management of HIV care and treatment activities in phases. A central expectation is that the transition happens without interruptions that could endanger patients, meaning no gaps in treatment access, no breakdowns in follow-up, and no service disruptions that would put people living with HIV at risk.
The role of the successful applicant is not limited to direct service delivery. The award is structured so that the recipient provides significant technical assistance and capacity development to the local organization(s) that will ultimately assume full implementation responsibility. Over time, the recipient is expected to take on increasing technical assistance responsibilities while simultaneously transferring program implementation duties and financial management capabilities to the local partner. In practical terms, this implies strengthening local systems for planning, supervision, clinical mentoring, supply and logistics coordination, data quality, monitoring and evaluation, budgeting, compliance, and day-to-day operational management. The phased approach suggests a deliberate timeline where the local partner gradually becomes the primary driver of both the programmatic work and the financial stewardship, with the awardee acting as a supportive bridge to ensure stability, quality, and accountability during the transition.
A notable program emphasis is improving continuity and quality of care through stronger health information systems, specifically by integrating and institutionalizing Zambia's national electronic medical records (EMR) initiative. The intent is to ensure that patient information supports consistent clinical follow-up, reduces loss to follow-up, enables better tracking of treatment outcomes, and improves coordination across services. By embedding the national EMR approach into routine operations at supported sites, the program is designed to move beyond ad hoc data systems toward standardized records that help clinicians and program managers make timely decisions. This also aligns with broader PEPFAR priorities around data-driven program management and reliable reporting, while making patient care more seamless at the facility level.
The opportunity is offered by the Centers for Disease Control and Prevention under a discretionary funding mechanism, and the funding instrument is a cooperative agreement. A cooperative agreement typically means CDC expects to have substantial involvement in the project beyond standard grant oversight, such as collaboration on technical direction, performance monitoring, and alignment with U.S. Government and national HIV program priorities. The activity category is health, and the CFDA number listed is 93.067 (Global AIDS). The announcement anticipated two awards, with an estimated total funding level of $100,000,000 across the awards. No cost sharing or matching requirement was stated. Award ceiling and floor were listed as $0 in the notice, which often indicates the specific limits are defined elsewhere in the full announcement or that awards are determined based on programmatic need and available funds rather than fixed caps.
Eligibility was broad and included many organization types that could plausibly implement large-scale health programs and provide technical assistance. Eligible applicants included nonprofits (with or without 501(c)(3) status), for-profit organizations (including entities other than small businesses), small businesses including small, minority-, and women-owned businesses, universities and colleges, research institutions, hospitals, community-based organizations, and faith-based organizations. Government eligibility extended to U.S. state and local governments (and their bona fide agents) and federally or state-recognized American Indian/Alaska Native tribal governments. The announcement also allowed non-U.S. (non-domestic) entities to apply, which is especially relevant given the work is based in Zambia. For any applicant applying as a bona fide agent of a state or local government, the opportunity required documentation (a letter from the relevant government) to confirm that status, submitted as an attachment through Grants.gov.
In terms of timing and administrative details, the opportunity was posted on February 14, 2011, with an original closing date of April 13, 2011, and a revised closing date of April 20, 2011. The archive date was May 20, 2011, indicating the opportunity is historical rather than currently open. Applicants were directed to consult the full announcement for complete requirements and details, including the appendix listing supported sites. For technical difficulties accessing the full announcement, the point of contact listed was the CDC Procurement and Grants Office, Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
Overall, the grant is best understood as a large-scale service continuity and transition effort under PEPFAR: maintain and scale HIV prevention, care, support, and treatment at established sites; prevent any dangerous service interruptions; build and transfer local capacity so Zambian partners can run the program and finances independently; and strengthen long-term continuity of care through adoption of the national EMR system. The combination of direct service support, structured technical assistance, and institutionalization of health information systems reflects a long-term sustainability goal: keeping patients stable on care while moving operational ownership to local organizations in a managed, accountable way.
Frequently Asked Questions (FAQs) - CDC RFA GH11-1119 (Zambia HIV Service Continuity and Transition)
1) What is CDC RFA GH11-1119 focused on?
CDC RFA GH11-1119 is a PEPFAR-supported cooperative agreement designed to keep HIV services in Zambia stable and growing while program responsibility is deliberately transitioned to local leadership. The emphasis is on continuity of HIV/AIDS prevention, clinical care, support services, and antiretroviral treatment (ART) that were already established under a prior PEPFAR-funded HHS/HRSA HIV clinical services and ART program.
2) Is this opportunity meant to start a brand-new HIV program?
No. The opportunity is structured to sustain and continue HIV services that were previously established, particularly at a defined set of HHS/HRSA-supported sites (listed in an appendix in the full announcement). The intent is an orderly handoff, not building a new program from scratch.
3) Where will the supported activities take place?
The work is based in Zambia, with particular attention to a defined set of HHS/HRSA-supported sites referenced in an appendix to the full announcement.
4) What is the main program goal during the transition?
The main goal is to transition implementation responsibility from an existing implementing partner to selected local organization(s) in phases, while avoiding interruptions that could endanger patients. This includes preventing gaps in treatment access, breakdowns in follow-up, and service disruptions that would put people living with HIV at risk.
5) What HIV services are expected to be sustained under this award?
The award supports continuity of HIV/AIDS prevention, clinical care, support services, and antiretroviral treatment (ART) that were previously established under the earlier PEPFAR-funded HHS/HRSA program.
6) What does a "phased" transition mean in this context?
A phased transition means program delivery and management responsibilities are shifted gradually to local organization(s) over time. The award is intended to support an orderly handoff so that local partners increasingly take on implementation and financial stewardship while continuity and quality of services are maintained.
7) What role does the recipient play besides delivering services?
The recipient is expected to provide significant technical assistance and capacity development to the local organization(s) that will ultimately assume full implementation responsibility. The award structure anticipates the recipient acting as a supportive bridge to ensure stability, quality, and accountability as responsibilities move to local partners.
8) What kinds of capacity development are expected for local partners?
The opportunity describes strengthening local systems and capabilities for planning, supervision, clinical mentoring, supply and logistics coordination, data quality, monitoring and evaluation, budgeting, compliance, and day-to-day operational management. It also includes transferring program implementation duties and financial management capabilities in a deliberate, phased manner.
9) How is financial management handled during the transition?
The expectation is that program implementation duties and financial management capabilities are gradually transferred to the local partner. Over time, the local partner becomes the primary driver of both program delivery and financial stewardship, with the awardee supporting and guiding that transition.
10) Why is continuity of care emphasized so strongly?
Because interruptions in HIV care and treatment can directly harm patients. The opportunity explicitly emphasizes preventing dangerous service disruptions, including avoiding gaps in treatment access and breakdowns in follow-up that could increase risk for people living with HIV.
11) What is the role of electronic medical records (EMRs) in this program?
A key emphasis is improving continuity and quality of care by strengthening health information systems and integrating/institutionalizing Zambia's national electronic medical records (EMR) initiative. The intent is for patient information to support consistent clinical follow-up, reduce loss to follow-up, improve tracking of treatment outcomes, and strengthen coordination across services.
12) What does it mean to "integrate and institutionalize" the national EMR initiative?
It means embedding the national EMR approach into routine operations at supported sites so the program moves away from ad hoc data systems toward standardized records that clinicians and program managers can rely on for timely decisions and reliable reporting.
13) How does the EMR emphasis connect to broader program priorities?
The described EMR work aligns with PEPFAR priorities around data-driven program management and reliable reporting, while also making patient care more seamless at the facility level by supporting consistent clinical follow-up and outcome tracking.
14) What type of funding instrument is used for this opportunity?
The funding instrument is a cooperative agreement under a discretionary funding mechanism.
15) What does it mean that this is a cooperative agreement?
The notice explains that a cooperative agreement typically means CDC expects to have substantial involvement beyond standard grant oversight. This can include collaboration on technical direction, performance monitoring, and alignment with U.S. Government and national HIV program priorities.
16) What is the activity category and CFDA number?
The activity category is health, and the CFDA number listed is 93.067 (Global AIDS).
17) How many awards were anticipated and what was the estimated total funding level?
The announcement anticipated two awards, with an estimated total funding level of $100,000,000 across the awards.
18) Was cost sharing or matching required?
No cost sharing or matching requirement was stated in the information provided.
19) Why do the award ceiling and floor show as $0?
The notice listed the award ceiling and floor as $0, which often indicates that specific limits are defined elsewhere in the full announcement or that award amounts are determined based on programmatic need and available funds rather than fixed caps.
20) Who was eligible to apply?
Eligibility was broad and included nonprofits (with or without 501(c)(3) status), for-profit organizations (including entities other than small businesses), small businesses (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based organizations, and faith-based organizations. Government eligibility included U.S. state and local governments (and their bona fide agents) and federally or state-recognized American Indian/Alaska Native tribal governments. Non-U.S. (non-domestic) entities were also allowed to apply.
21) Are non-U.S. organizations allowed to apply?
Yes. The announcement allowed non-U.S. (non-domestic) entities to apply, which is relevant because the work is based in Zambia.
22) What is required if applying as a bona fide agent of a state or local government?
If an applicant applies as a bona fide agent of a state or local government, the opportunity required documentation to confirm that status. Specifically, a letter from the relevant government had to be submitted as an attachment through Grants.gov.
23) When was the opportunity posted and when did it close?
The opportunity was posted on February 14, 2011. The original closing date was April 13, 2011, and the revised closing date was April 20, 2011.
24) Is this funding opportunity currently open?
No. The archive date was May 20, 2011, which indicates this is a historical opportunity rather than a currently open competition.
25) Where can applicants find the list of supported sites?
The supported sites were referenced as being listed in an appendix in the full announcement.
26) Who was the point of contact for technical difficulties accessing the full announcement?
For technical difficulties accessing the full announcement, the point of contact listed was the CDC Procurement and Grants Office, Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
27) What is the grant ultimately trying to achieve over the long term?
Based on the description provided, the long-term aim is sustainability: maintain and scale HIV prevention, care, support, and treatment at established sites; prevent any dangerous service interruptions; build and transfer local capacity so Zambian partners can manage the program and finances independently; and strengthen long-term continuity of care through adoption of the national EMR system.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Provision of HIV/AIDS Treatment Services by Local Indigenous Entities in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Universal Newborn Hearing Screening and Intervention
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1119
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1119) also looked into and applied for these:
| Funding Opportunity |
|---|
| Provision of HIV/AIDS Treatment Services by Local Indigenous Entities in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1127 Funding Number: CDC RFA GH11 1127 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza like Illness (U01) Apply for RFA CK 11 007 Funding Number: RFA CK 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01) Apply for PA 11 121 Funding Number: PA 11 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of Institutions of Uniformed Services in the Federal Democratic Republic of Ethiopia to Deliver Comprehensive HIV/AIDS Prevention, Care, Treatment, and Support Services under the President s Emergency Plan for AIDS Relief Apply for CDC RFA GH11 1166 Funding Number: CDC RFA GH11 1166 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,101,253 |
| Supporting the Rwandan Ministry of Health with Transition to Achieve Sustainable Public Health Program Implementation under the President s Emergency Plan for AIDS Relief (PEPFAR) and the Global Health Initiative Apply for CDC RFA GH11 1187 Funding Number: CDC RFA GH11 1187 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Institutional Strengthening to Improve Quality of Health Care Services in Haiti Through Well Trained Health Care Professional under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11100 Funding Number: CDC RFA GH11 11100 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS11 1115 Funding Number: CDC RFA PS11 1115 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $125,000 |
| Addressing TB Control and Lung Health Activities through the Vietnam National Lung Hospital/National TB Program (NLH/NTP) Apply for CDC RFA PS11 1110 Funding Number: CDC RFA PS11 1110 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Human Resources for Health through Continuing Education of Health Workers in the Federal Democratic Republic of Ethiopia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1167 Funding Number: CDC RFA GH11 1167 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Supporting The Implementation And Evaluation Of HIV/AIDS And Other Infectious And Non Infectious Diseases, Emerging Infections And Neglected Tropical Diseases In The Republic Of Nigeria Under PEPFAR Apply for CDC RFA PS09 9610301SUPP11 Funding Number: CDC RFA PS09 9610301SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Providing Technical Assistance for the Development and Implementation of Government of Botswana Driven Multi Component National HIV Prevention Campaigns under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1141 Funding Number: CDC RFA GH11 1141 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Technical Assistance to Strengthen and Ensure the Sustainability of the United Republic of Tanzania s Field Laboratory Epidemiology Training Program (FELTP) under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1143 Funding Number: CDC RFA GH11 1143 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Strengthening Infection Control and Prevention in Health Care Facilities in Zimbabwe under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1144 Funding Number: CDC RFA GH11 1144 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NHLBI Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD Fellows (F30) Apply for PA 11 125 Funding Number: PA 11 125 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R21) Apply for PA 11 124 Funding Number: PA 11 124 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R01) Apply for PA 11 123 Funding Number: PA 11 123 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Silvio O. Conte Centers for Basic and Translational Mental Health Research (P50) Apply for PAR 11 126 Funding Number: PAR 11 126 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Virologic Evaluation of the Modes of Influenza Virus Transmission among Humans (U01) Apply for RFA IP 11 001 Funding Number: RFA IP 11 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIH HMO Collaboratory Coordinating Center Limited Competition (U54) Apply for RFA RM 11 003 Funding Number: RFA RM 11 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Chemical Approaches to Target Validation for Drug Resistant Pathogens (R01) Apply for RFA AI 11 004 Funding Number: RFA AI 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1119", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.